A Kentucky woman has sued Takeda Pharmaceuticals USA Inc. in Illinois federal court, claiming the company’s heartburn drug Dexilant is to blame for her development of chronic kidney disease.

According to HarrisMartin Publishing, Kathy Weiter filed her lawsuit Dec. 8 in U.S. District Court for the Northern District of Illinois, alleging Takeda ignored evidence linking Dexilant to a variety of kidney-related ailments and failed to adequately warn patients and their physicians of known risks associated with the drug.

Dexilant belongs to a class of drugs known as Proton Pump Inhibitors (PPI), which are prescribed to millions of Americans. PPIs are a specific type of medication used to relieve symptoms of acid reflux, heartburn, and gastroesophageal reflux disease (GERD). They work by reducing the amount of stomach acid produced by the glands in the stomach. The first PPI, omeprazole, was released in the United States in 1990 and sold under the brand name Prilosec. Along with it’s European counterpart Losec, omeprazole quickly became one of the world’s best selling drugs.

After 13 years on the market as a prescription medication, the FDA approved an over-the-counter version of Prilosec in 2003. With the advent of additional OTC proton pump inhibitors, these drugs have consistently ranked in the top grossing medications in the country for years. In fact, approximately 15 million Americans use and/or are prescribed PPIs, making it the most commonly prescribed type of drug in the United States.

Our No-Fee Promise On Abilify Cases

You can afford to have our great team of Abilify lawyers on your side. If you choose us, it literally costs you nothing to get started. We promise you in writing:

  • No money to get started
  • We pay all case costs and expenses
  • No legal fees whatsoever unless you receive an Abilify settlement
  • Phone calls are always free

Legal Action Against Proton Pump Inhibitors

In the last few years, multiple lawsuits against PPI manufacturers have been settled for large amounts. In February 2015, AstraZeneca settled another lawsuit for $7.9 million against the United States Government alleging that the company engaged in a kickback scheme that was in violation of the False Claims Act.

Another PPI manufacturer, Teva Pharmaceuticals, settled a class action lawsuit for $24 million in June 2015. This lawsuit alleged that Teva intentionally withheld a generic version of Nexium off the market after it was found that they were paid off by AstraZeneca.

Studies and reports on PPI complications coupled with the recent history of lawsuits against these companies has prompted attorneys to investigate cases for patients who have been harmed by these drugs. If you believe a PPI medication is responsible for complications you or your loved one has suffered, you may be eligible to file a lawsuit and recover compensation.

Start Your Proton Pump Inhibitor Lawsuit Claim

Our PPI lawyers will help you file your lawsuit. To get started, you can:

  1. Submit the Free Case Review Box on this page, or
  2. Call (866) 280-3417 any time of day to tell us about your case.

We will listen to your story and answer your questions. If you have claim, we will start immediately.

WARNING: There are strict time deadlines for filing proton pump inhibitor lawsuit claims.